SGLT2 Inhibition: Uric Acid Excretion Study

Clinical trial NCT05210517 · COMPLETED

Trial details

NCT number: NCT05210517
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2020-10-01
Primary completion: 2021-06-08
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.